Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00760500
Other study ID # SIVFRC
Secondary ID N01AI70005
Status Completed
Phase N/A
First received September 25, 2008
Last updated February 16, 2015
Start date January 2004
Est. completion date March 2014

Study information

Verified date February 2015
Source St. Jude Children's Research Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The surveillance of influenza virus among children with febrile reparatory complaints attending the pediatric clinic in Shantou is an epidemiologic study to identify the type (influenza A or B) and the subtype of Influenza A of the isolates from children with febrile respiratory complaints who attend the pediatric clinic of the first Affiliated Hospital, Shantou University Medical College, Shantou Guangdong, China. Also this study investigates the genetic composition of all segments of isolated strains using standard molecular techniques and to make available the new strains of influenza viruses isolated from such children for the formulation of influenza vaccines. Clinical manifestation of the respiratory illness is recorded and single nasopharyngeal swab is obtained from eligible children. Viral culture is performed on the nasopharyngeal secretions. If influenza is isolated, this is characterized if it belongs to influenza A or B. If the virus is characterized as influenza A, further antigenic studies is done to determine subtype of influenza. Viral isolates is further studied to determine the genetic composition of the virus. Information obtained from the viral isolates is shared with the WHO and the CDC.


Description:

OBJECTIVES

Primary objective:

- To identify the type (Influenza A or B) and the subtype of Influenza A of the isolates from children with febrile respiratory complaints who attend the pediatric clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, China.

Secondary objectives

- To investigate the genetic composition of all segments of isolated strains using standard molecular techniques.

- To make available the new strains of influenza viruses isolated from such children for the formulation of influenza vaccines.


Recruitment information / eligibility

Status Completed
Enrollment 13201
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender Both
Age group N/A to 18 Years
Eligibility Inclusion Criteria:

- Age: 0 day to 18 years.

- Patient was seen at the pediatric clinic of the First Affiliated Hospital within 7 days of the onset of signs and symptoms of febrile respiratory illness suspected to be of viral origin (temperature > 37.7ºC or reliable history of fever before being examined, and respiratory symptoms and signs such as cough, sore throat, and coryza).

- Parents agree to a nasopharyngeal specimen being taken by swab from their child.

Exclusion Criteria:

- Patient is too ill to tolerate a nasopharyngeal specimen swab.

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Nasopharyngeal Swab
Nasopharyngeal Swab

Locations

Country Name City State
China First Affiliated Hospital Shantou Guangdong

Sponsors (3)

Lead Sponsor Collaborator
St. Jude Children's Research Hospital National Institute of Allergy and Infectious Diseases (NIAID), The University of Hong Kong

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary To identify Influenza A or B and the subtype of Influenza A of the isolates from children with febrile respiratory complaints who attend the pediatric clinic of the First Affiliated Hospital, Shantou University Medical College. This is an epidemiologic study, there is no time frame. No
See also
  Status Clinical Trial Phase
Completed NCT06385821 - A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus Phase 3
Not yet recruiting NCT03895268 - Influenza A+B Test Kit Performance Study
Not yet recruiting NCT05928507 - FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol
Completed NCT05163730 - Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel N/A
Not yet recruiting NCT06392451 - LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia N/A
Completed NCT05354115 - Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. N/A
Completed NCT05897515 - LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia N/A
Active, not recruiting NCT04471038 - Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants Phase 1
Completed NCT05715515 - Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device N/A
Completed NCT05268939 - Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 N/A
Completed NCT05727202 - Project STARFISH - PRJ0002679
Recruiting NCT06124638 - Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use N/A
Completed NCT03743688 - Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
Completed NCT05630365 - Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal Swabs N/A
Completed NCT04245800 - Home Testing of Respiratory Illness
Suspended NCT04782336 - Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test N/A
Completed NCT06008457 - Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit